{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:36:19Z","timestamp":1791466579832,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["GA 309449"],"award-info":[{"award-number":["GA 309449"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203918\/Z\/16\/Z)"],"award-info":[{"award-number":["203918\/Z\/16\/Z)"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>STING-associated vasculopathy with onset in infancy (SAVI) is a type 1 interferonopathy manifesting as a pulmonary and vascular syndrome resulting from gain-of-function mutations in <jats:italic>TMEM173<\/jats:italic>, the gene encoding STING. Familial reports in the literature are sparse.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report a case series of SAVI in a three generation kindred, with a phenotype of interstitial lung disease (ILD) and rheumatoid factor positive polyarticular juvenile idiopathic arthritis (JIA). Current and historical medical records were reviewed for clinical and laboratory information. Whole blood from cases 1 and 2, plus stored appendicectomy tissue from case 3, underwent DNA sequencing of the <jats:italic>TMEM173<\/jats:italic> gene. Peripheral blood RNA was obtained from cases 1 and 2 for functional assessment of the <jats:italic>TMEM173<\/jats:italic> mutation. DNA sequencing identified the same heterozygous <jats:italic>TMEM173<\/jats:italic> mutation (c.463G\u2009&gt;\u2009A; p.Val155Met) in all three cases, consistent with a diagnosis of the autosomal dominant condition SAVI. Functional assessment of this mutation identified a prominent interferon signature which was confirmed on repeat testing.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>SAVI presented in this family as ILD with early onset juvenile rheumatoid arthritis. This condition should be considered in all rheumatoid arthritis patients with early-onset ILD and in all JIA patients with ILD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12969-020-00425-w","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T12:04:00Z","timestamp":1589285040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype"],"prefix":"10.1186","volume":"18","author":[{"given":"S. L. N.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. I.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. N.","family":"Hilliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. J.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"425_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu Y, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371:507\u201318.","journal-title":"N Engl J Med"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1172\/JCI79100","volume":"124","author":"N Jeremiah","year":"2014","unstructured":"Jeremiah N, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 2014;124:5516\u201320.","journal-title":"J Clin Invest"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.chest.2016.02.682","volume":"150","author":"C Picard","year":"2016","unstructured":"Picard C, et al. Severe pulmonary fibrosis as the first manifestation of Interferonopathy (TMEM173 mutation). Chest. 2016;150:e65\u201371.","journal-title":"Chest"},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","volume":"76","author":"N K\u00f6nig","year":"2017","unstructured":"K\u00f6nig N, et al. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis. 2017;76:468\u201372.","journal-title":"Ann Rheum Dis"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","volume":"12","author":"GI Rice","year":"2013","unstructured":"Rice GI, et al. Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 2013;12:1159\u201369.","journal-title":"Lancet Neurol"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","volume":"128","author":"GAM Sanchez","year":"2018","unstructured":"Sanchez GAM, et al. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128:3041\u201352.","journal-title":"J Clin Invest"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","volume":"138","author":"ML Fr\u00e9mond","year":"2016","unstructured":"Fr\u00e9mond ML, et al. Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. J Allergy Clin Immunol. 2016;138:1752\u20135..","journal-title":"J Allergy Clin Immunol"},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","volume":"1238","author":"YJ Crow","year":"2011","unstructured":"Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011;1238:91\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Crow YJ. Type I interferon\u2013mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213:2527\u201338.","journal-title":"J Exp Med"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1164\/rccm.201510-2102LE","volume":"194","author":"SL Clarke","year":"2016","unstructured":"Clarke SL, et al. Interstitial lung disease caused by STING-associated vasculopathy with onset in infancy. Am J Respir Crit Care Med. 2016;194:639\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"425_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/art.38998","volume":"67","author":"E Omoyinmi","year":"2015","unstructured":"Omoyinmi E, et al. Stimulator of interferon genes-associated vasculitis of infancy. Arthritis Rheum. 2015;67:808.","journal-title":"Arthritis Rheum"},{"key":"425_CR12","doi-asserted-by":"crossref","unstructured":"Raffaele CGL, et al. A patient with stimulator of interferon genes\u2013associated vasculopathy with onset in infancy without skin vasculopathy. Rheumatology. 2019;59:905\u20137.","DOI":"10.1093\/rheumatology\/kez444"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/art.40179","volume":"69","author":"LM de Carvalho","year":"2017","unstructured":"de Carvalho LM, et al. Musculoskeletal disease in MDA5-related type I Interferonopathy: a Mendelian mimic of Jaccoud's Arthropathy. Arthritis Rheum. 2017;69:2081\u201391.","journal-title":"Arthritis Rheum"},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","volume":"8","author":"MP Rodero","year":"2017","unstructured":"Rodero MP, et al. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun. 2017;8:2176.","journal-title":"Nat Commun"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"931342","DOI":"10.1155\/2011\/931342","volume":"2011","author":"A Picchianti Diamanti","year":"2011","unstructured":"Picchianti Diamanti A, Germano V, Bizzi E, Lagan\u00e0 B, Migliore A. Interstitial lung disease in rheumatoid arthritis in the era of biologics. Pulmonary Med. 2011;2011:931342.","journal-title":"Pulmonary Med"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00425-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-020-00425-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00425-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:56:14Z","timestamp":1620777374000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-020-00425-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/s12969-020-00425-w","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Leeds (East) Research Ethics Committee (REC reference: 10\/H1307\/2; IRAS project ID: 62971), UK.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the cases in this publication or their next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}